A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(281 sites)

United States

Clearview Cancer Institute, Huntsville, Alabama

The University of Arizona Cancer Center - North Campus, Tucson, Arizona

Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine, California

TRIO-US (Translational Research in Oncology-US), Los Angeles, California

UCLA Hematology/Oncology - Santa Monica, Los Angeles, California